Sinee Weschawalit on Muck Rack

Sinee Weschawalit

As seen in: Wiley Online Library, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sinee

Contact Sinee, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Bullous pemphigoid and diabetes mellitus: a systematic review and meta‐analysis

|
By Sinee Weschawalit, Nuttapatch Jiirasutat, Padcha Pongchareon
| Wiley Online Library Verified
References 1, , , . Bullous pemphigoid: an immune disorder related to aging (Review). Exp Ther Med. 2022; 23(1): 50. https://doi.org/10.3892/etm.2021.10972 2, , , , . Increased frequency of diabetes mellitus in patients with bullous pemphigoid: a case-control study. J Am Acad Dermatol. 1984; 11(6): 1099–1102. https://doi.org/10.1016/s0190-9622(84)70266-0 3, , , . Bullous pemphigoid and autoimmunity. J Am Acad Dermatol. 1993; 29(2 Pt 1): 181–184. https://doi.org/10.1016/0190-9622(93)70164-o 4, , .
Open in Who Shared Issue with article?

Cutaneous adverse events after COVID-19 vaccination

|
By Sinee Weschawalit, Padcha Pongcharoen, Worapop Suthiwartnarueput, Winchana Srivilaithon
| Dove Medical Press
Introduction The Coronavirus disease 2019 (COVID-19) pandemic, declared by the WHO, began in March 20201 and the first COVID-19 vaccine, an mRNA vaccine (Pfizer), was approved by the US FDA for Emergency Use Authorization.
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified